Neumora Therapeutics Inc. (NMRA) Company Profile & Statistics

Neumora Therapeutics Inc.
NMRA
(Nasdaq - US)
N/A
12.91
+0.50 (+4.03%)
in:usd•As of: Jul 26, 2024 15:59 UTC -4
Open
12.61
High
12.91
Low
12.35

About Neumora Therapeutics Inc.

CEO

Henry O. Gosebruch

Headquarters

490 arsenal way, suite 200

watertown, ma 02472, united states

Auditor

Ernst & Young LLP

Employees

124

Share Holders

N/A

Website

https://neumoratx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its therapeutic pipeline currently consists of clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora Therapeutics Inc. is based in WATERTOWN, Mass.

Neumora Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization ²	2.06B
Enterprise Value	1.88B
Enterprise Value/EBITDA (ttm)	-15.91
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.47
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-23.00%
Return on Assets (ttm)	N/A

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-117.93M
Net Income Avi to Common (ttm)	-106.75M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	N/A
52-Week Change	N/A
S&P500 52-Week Change	19.54%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	159.52M
Dividend Yield	0.00%
Float ⁴	117.41M
% Held by Insiders	26.40%
% Held by Institutions	47.65%

Balance Sheet

Total Cash (mrq)	422.71M
Total Cash Per Share (mrq)	2.65
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	17.99%
Quick Ratio (mrq)	17.99%
Book Value Per Share (mrq)	2.66

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.27
Free Cash Flow (ytd)	-42.95M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Neumora Therapeutics Inc.

Trade With A Regulated Broker